Skip to main content
. 2016 Jun 14;7(26):39345–39362. doi: 10.18632/oncotarget.10050

Figure 9. VSOR Cl channel blockers causes partial Beclin-1 inhibition in myocardial hypoxia-reoxygenation injury.

Figure 9

A., C. Western blot analysis; B. Cell viability was measured by the MTT-assay; D. intracellular H2O2 analysis. *P < 0.05 compared with sham group; #P < 0.05 compared with I/R group.